Recomendaciones para el uso de la hormona de crecimiento humana recombinante en pacientes pediátricos de talla baja en Colombia
| Autor: | Estefania Pinzon Serrano, Vladimir González López, Martin Toro Ramos, Jesús Argente Oliver, Liliana Isabel Barrero Garzón, Fredy Mendivelso Duarte, Nancy Yomayusa González, Camila Céspedes Salazar, Oscar Escobar, Paola Durán Ventura, Angélica González Patiño, Sandra Roa Rodríguez, Juan Llano Linares, Juan López Rivera, Johana Correa Saldarriaga, Jennyfer Monroy Espejo, Ana Velásquez Rodríguez, Natalia Mejía Gaviria, Claudia Heredia Ramírez, Adriana Lema Izquierdo, María Urueña Zuccardi, Nayive Gil Ochoa, Carolina Rojas Barrera, Diana Bareño Campos, Mónica Fernández Hernández, Liliana Mejía Zapata, Catalina Forero Ronderos, Paola Pedraza Flechas, Audrey Matallana Rhoadesa, Mario Angulo Mosquera, María Suarez Cárdenas, Álvaro Arango Villa, Marcela Fama Pereira, Samantha Muñoz Osorio, Martha Páez Espitia, Ángelo López Miranda, Johanna Vargas Rodríguez, Diego Ruíz Amaya, Luis Laverde Gaona, Giovana Manrique Torres, Andrea Castro Tobón, Dora Romero Acosta, Ana Castillo Gutiérrez, Olga Gómez Gómez, Eduardo Low Padilla, Juan Acevedo Peña |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
lcsh:Internal medicine
pediatrics enfermedades del sistema endocrino hormona de crecimiento humana enfermedadesdelsistemaendocrino lcsh:RC870-923 Growth hormone técnicasdediagnósticoendocrinológico Short stature Expert committee endocrine diagnostic techniques endocrine system diseases Nursing Informed consent Medicine lcsh:RC31-1245 Recombinant growth hormone estatura business.industry growth disorders Human growth hormone lcsh:Diseases of the genitourinary system. Urology hormonadecrecimientohumana técnicas de diagnóstico endocrinológico Body height pediatría Nephrology trastornosdelcrecimiento trastornos del crecimiento human growth hormone Regulatory agency medicine.symptom business |
| Zdroj: | Revista Colombiana de Nefrología, Vol 7, Iss 1, Pp 149-177 (2020) Revista Colombiana de Nefrología, Volume: 7, Issue: 1, Pages: 149-177, Published: 12 DEC 2020 |
| ISSN: | 2500-5006 2389-7708 |
| DOI: | 10.22265/acnef.7.1.375 |
| Popis: | resumen está disponible en el texto completo Abstract In Colombia there are no guidelines for diagnosis and management of patients with short stature and for the use of recombinant human growth hormone, mainly caused by the diversity of training centers in pediatric endocrinology. In response to this situation, the Asociación Colegio Colombiana de Endocrinología Pediátrica leds the first colombian short stature expert committee in order to standardize the use of human recombinant growth hormone. This work had the participation and endorsement of a consortium of clinical experts representing the Sociedad Colombiana de Pediatría, Secretaría Distrital de Salud de Bogotá- Subred Integrada de Servicios de Salud Suroccidente, Fundación Universitaria Sanitas, Universidad de los Andes and some public and private health institutions in the country, in addition to the participation of methodological experts from the Instituto Global de Excelencia Clínica Keralty. By reviewing the literature and with the best available evidence, we proposed to unify definitions, a diagnostic algorithm, biochemical and dynamic tests with their reference parameters, a description of the considerations about growth hormone use among the indications approved by regulatory agency for medications and food in Colombia and finally a proposal for an informed consent and a medication fact sheet available for parents and patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|